ADVERTISEMENT
Today: The WHO-backed Covax initiative will get a boost from Moderna, but it won't do much for short-term supply issues. Speaker Pelosi said a return to normalcy won't happen until more lawmakers get vaccinated, and the CDC said a brief Ebola epidemic in the Congo is now over.
Moderna providing up to 500M vaccine doses to Covax program for lower-income countries
Moderna committed to providing up to 500 million doses of its COVID-19 vaccine to a United Nations-backed initiative designed to supply vaccinations to middle- and low-income countries.
The company announced an agreement with Gavi, the Vaccine Alliance to sell an initial 34 million doses to COVAX at the "lowest tiered price" within the fourth quarter of this year. The deal also permits Gavi to purchase 466 million additional vaccine doses in 2022.